SGN-00101 Immunotherapy in Treating Patients With Grade III Cervical Intraepithelial Neoplasia - Related Studies

SGN-00101 Immunotherapy in Treating Patients With Grade III Cervical Intraepithelial Neoplasia

This study has been completed.

Study NCT00075569. Last updated on September 4, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Cervical Cancer
		Precancerous/Nonmalignant Condition

2	Additional conditions recognized in this trial
		Cervical Intraepithelial Neoplasia
		Precancerous Conditions
		Uterine Cervical Neoplasms

3	More general conditions related to this trial
		Carcinoma
		Carcinoma in Situ
		Genital Diseases, Female
		Genital Neoplasms, Female
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Glandular and Epithelial
		Urogenital Neoplasms
		Uterine Cervical Diseases
		Uterine Diseases
		Uterine Neoplasms

4	Interventions listed in this trial
		HspE7

5	Sponsors listed in this trial
		Albert Einstein College of Medicine of Yeshiva University
		National Cancer Institute (NCI)